Abstract:As an important biomarker for early Alzheimer’s disease (AD) diagnostics and a valuable therapeutic target, amyloid β peptide (Aβ) in blood has attracted extensive attention concerning its detection and monitoring. The tough challenges for monitoring subtle changes of Aβ in blood are low expression and high interference from environmental factors. Here, we constructed a ratiometric sensor based on dual-emission luminescent lanthanide metal–organic coordination polymer (DE-LMOCP) as fluorescence probe for simple, sensitive and accurate detection of Aβ. The DE-LMOCP (luminol-Tb-GMP-Cu) fluorescent probe was composed of terbium ion(Tb3+) as the center metal ions, cupric ion(Cu2+) as a cofactor for Tb3+ fluorescence silence, guanine monophosphate (GMP) as a bridging ligand can strengthen the fluorescence of Tb3+, and luminol as an auxiliary ligand. In the DE-LMOCP fluorescent probe, the fluorescence of the GMP-Tb is quite weak because the existing cofactor Cu2+ prevents the energy transfer of intramolecular between GMP and Tb3+ and results in the quench of GMP-Tb fluorescence. The fluorescence of luminol acts as inner reference. In the presence of Aβ, the high binding affinity of Aβ for Cu2+ causes a remarkable emission enhancement of GMP-Tb and suppresses the quenching effect. However, the fluorescence emission of luminol remains constant as inner reference. Hence, sensitive and accurate determination of Aβ were performed by the ratio of the fluorescence of luminol (F430) to the Tb3+(F547). With this ratiometric probe, Aβ was determined with sensitivity down to 20 pM. Moreover, the ratiometric probe was successfully used to the detection of Aβ in human plasma with satisfactory results due to its capability to eliminate auto-fluorescence. Significantly, it exhibited sound specificity and selectivity to recognize Aβ1−40, and successfully applied to visual detection of Aβ, which validates the potential on-site application. Given the analytical characteristics with high sensitivity, specificity, and accuracy, the ratiometric fluorescence sensor may have great potential in applications of Aβ1−40 detection and the early diagnosis of Alzheimer’s disease, as well as point-of-care tests.

Clinical Chemistry Route for Investigation of Alzheimer's Disease: A Label-Free Electrochemiluminescent Biosensor for Glycogen Synthase Kinase-3 Beta

Paper-based electrochemiluminescence sensor for highly sensitive detection of amyloid-β oligomerization: Toward potential diagnosis of Alzheimer's disease.

Highly sensitive in-situ growth gold dendrite structure electrochemical sensor for early Alzheimer's disease screening

Gelsolin bound β-amyloid peptides(1-40/1-42): electrochemical evaluation of levels of soluble peptide associated with Alzheimer's disease.

Ultrasensitive and point-of-care detection of plasma phosphorylated tau in Alzheimer's disease using colorimetric and surface-enhanced Raman scattering dual-readout lateral flow assay

Simultaneous Detection of Alzheimer's Biomarkers using a Visual Electrochemiluminescence Bipolar Array

Electrochemical Detection of Alzheimer's Disease Related Substances in Biofluids by Silica Nanochannel Membrane Modified Glassy Carbon Electrodes

A Hydrogel Biosensor for High Selective and Sensitive Detection of Amyloid-Beta Oligomers

Ultrasensitive Electrochemiluminescence Immunosensor for the Detection of Amyloid-Β Proteins Based on Resonance Energy Transfer Between G-C3n4 and Pd NPs Coated NH2-MIL-53.

Dry Chemistry-Based Bipolar Electrochemiluminescence Immunoassay Device for Point-of-Care Testing of Alzheimer-Associated Neuronal Thread Protein

G-C3n4-heme Bound to Amyloid Β Peptides: In-situ Generation of the Secondary Co-Reactant for Dual-Enhanced Electrochemiluminescence Assay of Amyloid Β Detection

Microbiosensor for Alzheimer's disease diagnostics: detection of amyloid beta biomarkers.

Implementation of an ultra-sensitive microwell-based electrochemical sensor for the detection of Alzheimer's disease

Application of aminobenzoic acid electrodeposited screen-printed carbon electrode in the beta-amyloid electrochemical impedance spectroscopy immunoassay

Recent Advances in Electrochemical Biosensors for the Detection of Aβ42, a Biomarker for Alzheimer Disease Diagnosis

Gelsolin Encountering Ag Nanorods/Triangles: an Aggregation-Based Colorimetric Sensor Array for in Vivo Monitoring the Cerebrospinal Aβ42% As an Indicator of Cd2+ Exposure-Related Alzheimer’s Disease Pathogenesis

Confinement-enhanced electrochemiluminescence of copper nanoclusters on 3D layered double hydroxide for ultrasensitive detection of GFAP

Competitive electrochemical immunoassay for detection of β-amyloid (1-42) and total β-amyloid peptides using p-aminophenol redox cycling.

An Ultrasensitive Molecularly Imprinted Point-Of-Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein

Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-β biomarker of Alzheimer's disease

Efficient ratiometric fluorescence probe based on dual-emission luminescent lanthanide coordination polymer for amyloid β-peptide detection